Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS Negl Trop Dis ; 10(8): e0004910, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27509077

RESUMO

BACKGROUND: Many U.S.-bound refugees travel from countries where intestinal parasites (hookworm, Trichuris trichuria, Ascaris lumbricoides, and Strongyloides stercoralis) are endemic. These infections are rare in the United States and may be underdiagnosed or misdiagnosed, leading to potentially serious consequences. This evaluation examined the costs and benefits of combinations of overseas presumptive treatment of parasitic diseases vs. domestic screening/treating vs. no program. METHODS: An economic decision tree model terminating in Markov processes was developed to estimate the cost and health impacts of four interventions on an annual cohort of 27,700 U.S.-bound Asian refugees: 1) "No Program," 2) U.S. "Domestic Screening and Treatment," 3) "Overseas Albendazole and Ivermectin" presumptive treatment, and 4) "Overseas Albendazole and Domestic Screening for Strongyloides". Markov transition state models were used to estimate long-term effects of parasitic infections. Health outcome measures (four parasites) included outpatient cases, hospitalizations, deaths, life years, and quality-adjusted life years (QALYs). RESULTS: The "No Program" option is the least expensive ($165,923 per cohort) and least effective option (145 outpatient cases, 4.0 hospitalizations, and 0.67 deaths discounted over a 60-year period for a one-year cohort). The "Overseas Albendazole and Ivermectin" option ($418,824) is less expensive than "Domestic Screening and Treatment" ($3,832,572) or "Overseas Albendazole and Domestic Screening for Strongyloides" ($2,182,483). According to the model outcomes, the most effective treatment option is "Overseas Albendazole and Ivermectin," which reduces outpatient cases, deaths and hospitalization by around 80% at an estimated net cost of $458,718 per death averted, or $2,219/$24,036 per QALY/life year gained relative to "No Program". DISCUSSION: Overseas presumptive treatment for U.S.-bound refugees is a cost-effective intervention that is less expensive and at least as effective as domestic screening and treatment programs. The addition of ivermectin to albendazole reduces the prevalence of chronic strongyloidiasis and the probability of rare, but potentially fatal, disseminated strongyloidiasis.


Assuntos
Helmintíase/tratamento farmacológico , Helmintíase/economia , Enteropatias Parasitárias/tratamento farmacológico , Enteropatias Parasitárias/economia , Programas de Rastreamento/economia , Refugiados , Ancylostomatoidea/isolamento & purificação , Animais , Ascaríase/diagnóstico , Ascaríase/tratamento farmacológico , Ascaríase/economia , Ascaríase/epidemiologia , Ascaris lumbricoides/isolamento & purificação , Ásia/epidemiologia , Análise Custo-Benefício , Intervenção Médica Precoce/economia , Helmintíase/diagnóstico por imagem , Helmintíase/epidemiologia , Infecções por Uncinaria/diagnóstico , Infecções por Uncinaria/tratamento farmacológico , Infecções por Uncinaria/economia , Infecções por Uncinaria/epidemiologia , Hospitalização/economia , Hospitalização/estatística & dados numéricos , Humanos , Enteropatias Parasitárias/diagnóstico por imagem , Enteropatias Parasitárias/epidemiologia , Modelos Econômicos , Prevalência , Strongyloides stercoralis/isolamento & purificação , Estrongiloidíase/diagnóstico , Estrongiloidíase/tratamento farmacológico , Estrongiloidíase/economia , Estrongiloidíase/epidemiologia , Tricuríase/diagnóstico , Tricuríase/tratamento farmacológico , Tricuríase/economia , Tricuríase/epidemiologia , Trichuris/isolamento & purificação , Estados Unidos/epidemiologia
2.
PLoS Negl Trop Dis ; 2(9): e300, 2008 Sep 24.
Artigo em Inglês | MEDLINE | ID: mdl-18820747

RESUMO

The neglected tropical diseases (NTDs) represent some of the most common infections of the poorest people living in the Latin American and Caribbean region (LAC). Because they primarily afflict the disenfranchised poor as well as selected indigenous populations and people of African descent, the NTDs in LAC are largely forgotten diseases even though their collective disease burden may exceed better known conditions such as of HIV/AIDS, tuberculosis, or malaria. Based on their prevalence and healthy life years lost from disability, hookworm infection, other soil-transmitted helminth infections, and Chagas disease are the most important NTDs in LAC, followed by dengue, schistosomiasis, leishmaniasis, trachoma, leprosy, and lymphatic filariasis. On the other hand, for some important NTDs, such as leptospirosis and cysticercosis, complete disease burden estimates are not available. The NTDs in LAC geographically concentrate in 11 different sub-regions, each with a distinctive human and environmental ecology. In the coming years, schistosomiasis could be eliminated in the Caribbean and transmission of lymphatic filariasis and onchocerciasis could be eliminated in Latin America. However, the highest disease burden NTDs, such as Chagas disease, soil-transmitted helminth infections, and hookworm and schistosomiasis co-infections, may first require scale-up of existing resources or the development of new control tools in order to achieve control or elimination. Ultimately, the roadmap for the control and elimination of the more widespread NTDs will require an inter-sectoral approach that bridges public health, social services, and environmental interventions.


Assuntos
Doença de Chagas/epidemiologia , Medicina Tropical/economia , Síndrome da Imunodeficiência Adquirida/epidemiologia , Doença de Chagas/economia , Criança , Efeitos Psicossociais da Doença , Infecções por HIV/epidemiologia , Infecções por Uncinaria/economia , Infecções por Uncinaria/epidemiologia , Humanos , Renda , América Latina/epidemiologia , Pobreza , Esquistossomose mansoni/economia , Esquistossomose mansoni/epidemiologia , Magreza/economia , Magreza/epidemiologia , Clima Tropical , Medicina Tropical/estatística & dados numéricos , Índias Ocidentais/epidemiologia , Organização Mundial da Saúde
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA